PROVIDER PROFILE · NPI 1730403841
Rebecca LapatingPA-C
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
687
Unique beneficiaries
—
Total services
709
Distinct HCPCS
12
Medicare payment
$38K
PRESCRIBING · PART D · 2024
Total Rx claims
233
Beneficiaries
—
Total drug cost
$2K
Distinct drugs
12
Brand share
52.8%
Top prescribed drugs
Amoxicillin/Potassium Clav32 claims
Cephalexin32 claims
Nitrofurantoin Monohyd/M-Cryst28 claims
Sulfamethoxazole/Trimethoprim28 claims
Nirmatrelvir/Ritonavir20 claims
QUALITY · MIPS · 2024
Final MIPS score
87.5
Quality
84.1
Cost
74.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.53%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Rebecca Lapating's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Bryan Doonan Family Practice · Newport Beach, CA | 41 | 68 |
| Primex Clinical Laboratories Inc. Clinical Laboratory · Van Nuys, CA | 37 | 68 |
| Unilab Corporation Clinical Laboratory · West Hills, CA | 11 | 16 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE